# Dauntless Investment Group, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 2044285. Source: https://holderbook.com/funds/2044285-dauntless-investment-group-llc/

- Reported value: $127.3M
- Positions: 73
- Weight of the ten largest: 72.4%
- Filed: 2026-08-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| ISHARES TR | [IWM](https://holderbook.com/stocks/IWM/) | $36.1M | 0 | 28.3% | 2 |
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $12.0M | 0 | 9.4% | 1 |
| ELECTRONIC ARTS INC | [EA](https://holderbook.com/stocks/EA/) | $9.4M | 0 | 7.4% | 1 |
| AEON BIOPHARMA INC | [AEON](https://holderbook.com/stocks/AEON/) | $9.0M | 12,490,154 | 7.1% | 6 |
| FEMASYS INC | - | $7.8M | 1,867,987 | 6.1% | 1 |
| KAZIA THERAPEUTICS LTD | [KZIA](https://holderbook.com/stocks/KZIA/) | $5.0M | 354,208 | 3.9% | 5 |
| VANECK ETF TRUST | [SMH](https://holderbook.com/stocks/SMH/) | $4.7M | 0 | 3.7% | 1 |
| SPDR SERIES TRUST | [XBI](https://holderbook.com/stocks/XBI/) | $3.2M | 0 | 2.5% | 1 |
| VALERO ENERGY CORP | [VLO](https://holderbook.com/stocks/VLO/) | $2.8M | 10,620 | 2.2% | 1 |
| ST JOE CO | [JOE](https://holderbook.com/stocks/JOE/) | $2.3M | 36,167 | 1.8% | 7 |
| ADAGENE INC | [ADAG](https://holderbook.com/stocks/ADAG/) | $2.3M | 537,230 | 1.8% | 2 |
| ESTABLISHMENT LABS HLDGS INC | [ESTA](https://holderbook.com/stocks/ESTA/) | $2.2M | 25,728 | 1.7% | 3 |
| IRSA INVERSIONES Y REP S A | [IRS](https://holderbook.com/stocks/IRS/) | $2.0M | 126,542 | 1.5% | 1 |
| AZITRA INC | [AZTR](https://holderbook.com/stocks/AZTR/) | $1.9M | 11,292,186 | 1.5% | 2 |
| LINCOLN EDL SVCS CORP | [LINC](https://holderbook.com/stocks/LINC/) | $1.5M | 31,046 | 1.2% | 7 |
| TIZIANA LIFE SCIENCES LTD | [TLSA](https://holderbook.com/stocks/TLSA/) | $1.5M | 1,162,000 | 1.2% | 6 |
| PROFOUND MED CORP | [PROF](https://holderbook.com/stocks/PROF/) | $1.4M | 208,369 | 1.1% | 3 |
| ARMATA PHARMACEUTICALS INC | [ARMP](https://holderbook.com/stocks/ARMP/) | $1.3M | 203,891 | 1.0% | 3 |
| LOMA NEGRA CORP | [LOMA](https://holderbook.com/stocks/LOMA/) | $1.3M | 115,186 | 1.0% | 1 |
| COURSERA INC | [COUR](https://holderbook.com/stocks/COUR/) | $1.3M | 224,171 | 1.0% | 6 |
| ALPHABET INC | [GOOG](https://holderbook.com/stocks/GOOG/) | $1.2M | 0 | 1.0% | 1 |
| UNIVERSAL TECHNICAL INST INC | [UTI](https://holderbook.com/stocks/UTI/) | $1.2M | 27,990 | 0.9% | 3 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $1.0M | 0 | 0.8% | 1 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $1.0M | 0 | 0.8% | 1 |
| QUOIN PHARMACEUTICALS LTD | [QNRX](https://holderbook.com/stocks/QNRX/) | $1.0M | 214,987 | 0.8% | 2 |
| SERVICENOW INC | [NOW](https://holderbook.com/stocks/NOW/) | $1.0M | 10,200 | 0.8% | 1 |
| UNICYCIVE THERAPEUTICS INC | [UNCY](https://holderbook.com/stocks/UNCY/) | $1.0M | 214,000 | 0.8% | 3 |
| META PLATFORMS INC | [META](https://holderbook.com/stocks/META/) | $957.6K | 0 | 0.8% | 1 |
| CRESUD S A C I F Y A | [CRESY](https://holderbook.com/stocks/CRESY/) | $898.9K | 80,186 | 0.7% | 1 |
| THE ONCOLOGY INSTITUTE INC | [TOI](https://holderbook.com/stocks/TOI/) | $888.2K | 163,570 | 0.7% | 2 |
| PTC THERAPEUTICS INC | [PTCT](https://holderbook.com/stocks/PTCT/) | $831.4K | 10,193 | 0.7% | 3 |
| ALPHA TAU MEDICAL LTD | [DRTS](https://holderbook.com/stocks/DRTS/) | $769.9K | 61,200 | 0.6% | 1 |
| TALPHERA INC | [TLPH](https://holderbook.com/stocks/TLPH/) | $768.4K | 746,051 | 0.6% | 4 |
| CHURCHILL CAP CORP XI | [CCXI](https://holderbook.com/stocks/CCXI/) | $673.3K | 38,587 | 0.5% | 1 |
| MAREX GROUP PLC | [MRX](https://holderbook.com/stocks/MRX/) | $629.2K | 10,324 | 0.5% | 3 |
| MARATHON PETE CORP | [MPC](https://holderbook.com/stocks/MPC/) | $578.8K | 2,264 | 0.5% | 4 |
| UPWORK INC | [UPWK](https://holderbook.com/stocks/UPWK/) | $565.8K | 67,680 | 0.4% | 1 |
| NEURONETICS INC | [STIM](https://holderbook.com/stocks/STIM/) | $479.9K | 369,187 | 0.4% | 3 |
| COGNITION THERAPEUTICS INC | [CGTX](https://holderbook.com/stocks/CGTX/) | $427.5K | 371,701 | 0.3% | 3 |
| PILGRIMS PRIDE CORP | [PPC](https://holderbook.com/stocks/PPC/) | $385.7K | 13,721 | 0.3% | 2 |
| MAUI LD & PINEAPPLE INC | [MLP](https://holderbook.com/stocks/MLP/) | $344.3K | 19,362 | 0.3% | 5 |
| AIRSCULPT TECHNOLOGIES INC | [AIRS](https://holderbook.com/stocks/AIRS/) | $303.1K | 67,360 | 0.2% | 2 |
| GRUPO FINANCIERO GALICIA S.A | [GGAL](https://holderbook.com/stocks/GGAL/) | $211.1K | 4,220 | 0.2% | 1 |
| CAL MAINE FOODS INC | [CALM](https://holderbook.com/stocks/CALM/) | $207.9K | 2,581 | 0.2% | 2 |
| MOBILICOM LTD | [MOB](https://holderbook.com/stocks/MOB/) | $144.9K | 28,245 | 0.1% | 1 |
| SONIDA SENIOR LIVING INC | [SNDA](https://holderbook.com/stocks/SNDA/) | $143.7K | 3,521 | 0.1% | 1 |
| WELLTOWER INC | [WELL](https://holderbook.com/stocks/WELL/) | $140.5K | 619 | 0.1% | 1 |
| APYX MEDICAL CORPORATION | [APYX](https://holderbook.com/stocks/APYX/) | $135.8K | 30,249 | 0.1% | 1 |
| BROOKDALE SR LIVING INC | [BKD](https://holderbook.com/stocks/BKD/) | $73.5K | 4,571 | 0.1% | 1 |
| JANUS LIVING INC | [JAN](https://holderbook.com/stocks/JAN/) | $68.9K | 2,398 | 0.1% | 1 |
| TRAWS PHARMA INC | [TRAW](https://holderbook.com/stocks/TRAW/) | $67.9K | 80,574 | 0.1% | 2 |
| ERNEXA THERAPEUTICS INC | - | $39.9K | 6,000 | 0.0% | 1 |
| INNOVIVA INC | [INVA](https://holderbook.com/stocks/INVA/) | $36.8K | 1,620 | 0.0% | 3 |
| GRUPO CIBEST SA | [CIB](https://holderbook.com/stocks/CIB/) | $35.2K | 443 | 0.0% | 1 |
| AGNICO EAGLE MINES LTD | [AEM](https://holderbook.com/stocks/AEM/) | $25.6K | 165 | 0.0% | 7 |
| GLOBAL X FDS | [COLO](https://holderbook.com/stocks/COLO/) | $21.1K | 507 | 0.0% | 1 |
| HESAI GROUP | [HSAI](https://holderbook.com/stocks/HSAI/) | $20.0K | 1,100 | 0.0% | 1 |
| RENATUS TACTICAL ACQUIS | [RTAC](https://holderbook.com/stocks/RTAC/) | $19.0K | 1,813 | 0.0% | 5 |
| TEXAS VENTURES ACQUISITION I | [TVA](https://holderbook.com/stocks/TVA/) | $8.5K | 805 | 0.0% | 4 |
| JBS N.V. | [JBS](https://holderbook.com/stocks/JBS/) | $8.0K | 674 | 0.0% | 5 |
| AMERICAN EXCEPTIONALISM ACQU | [AEXA](https://holderbook.com/stocks/AEXA/) | $7.9K | 670 | 0.0% | 3 |
| CURIS INC | [CRISXXXX](https://holderbook.com/stocks/CRISXXXX/) | $5.2K | 10,001 | 0.0% | 2 |
| DOUBLELINE INCOME SOLUTIONS | [DSL](https://holderbook.com/stocks/DSL/) | $3.6K | 326 | 0.0% | 5 |
| ABRDN PLATINUM ETF TRUST | [PPLT](https://holderbook.com/stocks/PPLT/) | $3.4K | 240 | 0.0% | 7 |
| DAKOTA GOLD CORP | [DC](https://holderbook.com/stocks/DC/) | $2.5K | 581 | 0.0% | 2 |
| NEW AMER ACQUISITION I CORP | [NWAXU](https://holderbook.com/stocks/NWAXU/) | $1.8K | 172 | 0.0% | 3 |
| POWELL INDS INC | [POWL](https://holderbook.com/stocks/POWL/) | $286 | 1 | 0.0% | 1 |
| INMUNE BIO INC | [INMB](https://holderbook.com/stocks/INMB/) | $163 | 100 | 0.0% | 3 |
| LINEAGE CELL THERAPEUTICS IN | [LCTX](https://holderbook.com/stocks/LCTX/) | $131 | 100 | 0.0% | 1 |
| CAPRICOR THERAPEUTICS INC | [CAPR](https://holderbook.com/stocks/CAPR/) | $24 | 1 | 0.0% | 2 |
| TREVI THERAPEUTICS INC | [TRVI](https://holderbook.com/stocks/TRVI/) | $19 | 1 | 0.0% | 1 |
| HALL CHADWICK ACQUISITION CO | [HCAC](https://holderbook.com/stocks/HCAC/) | $10 | 1 | 0.0% | 1 |
| NORTHERN DYNASTY MINERALS LT | [NAK](https://holderbook.com/stocks/NAK/) | $2 | 1 | 0.0% | 7 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +2.6% | +14.8% | -12.2% | 87% |
| Q1 2026 | +5.2% | -4.6% | +9.9% | 119% |
| Q4 2025 | -0.7% | +2.4% | -3.0% | 99% |
| Q2 2025 | +19.5% | +10.5% | +9.0% | 68% |
| Q1 2025 | +8.5% | -4.6% | +13.0% | 85% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $127.3M | 73 |
| Q1 2026 | $151.0M | 68 |
| Q4 2025 | $125.9M | 66 |
| Q3 2025 | $160.0M | 65 |
| Q2 2025 | $57.5M | 68 |
| Q1 2025 | $85.4M | 54 |
| Q4 2024 | $95.1M | 60 |